Search research articles
Contact Us
Filters
Showing results (381-390 of 394) with videos related to
Page
of 40
Sort By:
Nature
|
May 27, 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi, Chao Shan, Xiaomin Duan, et al.
Science (New York, N.Y.)
|
February 8, 2022
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
Wanchao Yin, Youwei Xu, Peiyu Xu, et al.
Cell Research
|
June 18, 2020
Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis
Jun Wu, Dingyun Song, Zhongwen Li, et al.
The Lancet. Infectious Diseases
|
October 18, 2020
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia, Yuntao Zhang, Yanxia Wang, et al.
China CDC Weekly
|
October 1, 2021
Long Distance Transmission of SARS-CoV-2 from Contaminated Cold Chain Products to Humans - Qingdao City, Shandong Province, China, September 2020
Huilai Ma, Zhaoguo Wang, Xiang Zhao, et al.
Global Change Biology
|
July 6, 2021
Ambient climate determines the directional trend of community stability under warming and grazing
Peipei Liu, Wangwang Lv, Jianping Sun, et al.
Nature
|
April 5, 2023
Surveillance of SARS-CoV-2 at the Huanan Seafood Market
William J Liu, Peipei Liu, Wenwen Lei, et al.
Animal Models and Experimental Medicine
|
April 23, 2020
Age-related rhesus macaque models of COVID-19
Pin Yu, Feifei Qi, Yanfeng Xu, et al.
The Lancet. Infectious Diseases
|
September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
ShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Human Immunology
|
November 17, 2021
Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients
Haitao Xiang, Yingze Zhao, Xinyang Li, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 394) with videos related to
Sort By:
Page
of 40
Nature
|
May 27, 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi, Chao Shan, Xiaomin Duan, et al.
Science (New York, N.Y.)
|
February 8, 2022
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
Wanchao Yin, Youwei Xu, Peiyu Xu, et al.
Cell Research
|
June 18, 2020
Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis
Jun Wu, Dingyun Song, Zhongwen Li, et al.
The Lancet. Infectious Diseases
|
October 18, 2020
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia, Yuntao Zhang, Yanxia Wang, et al.
China CDC Weekly
|
October 1, 2021
Long Distance Transmission of SARS-CoV-2 from Contaminated Cold Chain Products to Humans - Qingdao City, Shandong Province, China, September 2020
Huilai Ma, Zhaoguo Wang, Xiang Zhao, et al.
Global Change Biology
|
July 6, 2021
Ambient climate determines the directional trend of community stability under warming and grazing
Peipei Liu, Wangwang Lv, Jianping Sun, et al.
Nature
|
April 5, 2023
Surveillance of SARS-CoV-2 at the Huanan Seafood Market
William J Liu, Peipei Liu, Wenwen Lei, et al.
Animal Models and Experimental Medicine
|
April 23, 2020
Age-related rhesus macaque models of COVID-19
Pin Yu, Feifei Qi, Yanfeng Xu, et al.
The Lancet. Infectious Diseases
|
September 18, 2021
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
ShengLi Xia, YunTao Zhang, YanXia Wang, et al.
Human Immunology
|
November 17, 2021
Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients
Haitao Xiang, Yingze Zhao, Xinyang Li, et al.
Page
of 40